The two major types of IBD―Crohn’s disease and ulcerative colitis―present with overlapping but distinct symptoms. Crohn’s ...

The Consortium Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) published data on the global ...

Rebecca Hogan was stunned when she was diagnosed with Crohn’s disease in her early twenties. She didn’t know then about the ...

In time for May, which is Inflammatory Bowel Disease Awareness month, Crohn’s & Colitis Australia (CCA) have launched a ...

This new technique, called GlycoCaging, allows powerful medicines to reach the inflamed part of the gut using much lower ...

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease ...

The spatio-temporal evolution of inflammatory bowel disease across the world follows four epidemiological stages: emergence, acceleration in incidence, compounding prevalence and prevalence ...

Patients with IBD treated with the original adalimumab reference product show a high acceptance of the switch to its ...

Efficacy outcomes with subcutaneous infliximab (Zymfentra) for ulcerative colitis or Crohn's disease were largely comparable ...

UBC researchers say they've made a breakthrough in the treatment of a disease that affects hundreds of thousands of Canadians ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...